Literature DB >> 18395800

Clinical course of retrobulbar hemangioblastomas in von Hippel-Lindau disease.

Catherine B Meyerle1, Sam S Dahr, Nicholas M Wetjen, Guy V Jirawuthiworavong, John A Butman, Russell R Lonser, Edward Oldfield, Hanna Rodriguez-Coleman, Wai T Wong, Emily Y Chew.   

Abstract

OBJECTIVE: To report clinical findings of rare retrobulbar optic nerve hemangioblastomas associated with von Hippel-Lindau disease (VHL).
DESIGN: Retrospective observational case series. PARTICIPANTS: Nine patients with VHL.
METHODS: The clinical course and magnetic resonance imaging findings of patients with VHL and hemangioblastomas affecting the anterior visual pathway from the intraorbital optic nerve to the optic chiasm are reviewed. MAIN OUTCOME MEASURE: Clinical course of retrobulbar optic nerve hemangioblastomas.
RESULTS: The mean age of VHL diagnosis was 24+/-14 years, and mean follow-up was 5+/-4 years. All had other CNS lesions and retinal hemangioblastomas. Approximately 50% (5/9) had a previous enucleation or had visual acuity loss (4/9), some due to other VHL ocular complications. Four patients underwent surgical resection of an intracranial hemangioblastoma. Growth patterns and pathology are similar to those of other hemangioblastomas in the CNS.
CONCLUSIONS: Although these lesions are rare, patients with VHL who present with signs of optic neuropathy should be evaluated for anterior visual pathway hemangioblastomas impinging on the optic nerve from the orbit to the chiasm. On neuroimaging, the hemangioblastomas may demonstrate chiasmal or optic tract edema, associated cysts, and T(2) flow voids. Lesions may remain radiologically and clinically stable, evolve radiographically with no visual or neurological progression, or progress clinically and radiographically. Patients at risk for visual loss should be considered for surgical resection. Close coordination among neuroradiology, neurosurgery, and ophthalmology patient care teams is advised for optimal management of these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18395800     DOI: 10.1016/j.ophtha.2008.01.027

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease.

Authors:  Steven A Mills; Michael C Oh; Martin J Rutkowski; Michael E Sughrue; Igor J Barani; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2012-06-21       Impact factor: 12.300

2.  Retrobulbar Hemangioblastomas in von Hippel-Lindau Disease: Clinical Course and Management.

Authors:  Reinier Alvarez; Panagiotis Mastorakos; Elizabeth Hogan; Gretchen Scott; Russell R Lonser; Henry E Wiley; Emily Y Chew; Prashant Chittiboina
Journal:  Neurosurgery       Date:  2021-04-15       Impact factor: 4.654

3.  VHL-Associated Optic Nerve Hemangioblastoma Treated with Stereotactic Radiosurgery.

Authors:  Hiroshi Kanno; Seiki Osano; Masamichi Shinonaga
Journal:  J Kidney Cancer VHL       Date:  2018-06-06

4.  Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease.

Authors:  Blake N Staub; Andrew D Livingston; Patricia Chévez-Barrios; David S Baskin
Journal:  Surg Neurol Int       Date:  2014-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.